US Patent 9804170 Antibodies to polyethylene glycol
Patent 9804170 was granted and assigned to Bristol-Myers Squibb on October, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9804170 Antibodies to polyethylene glycol
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
